Clinically, large-scale validation in ESCC patient cohorts is essential to determine the prognostic and therapeutic relevance of correlations between RSF1, DAPK3, Ki-67, and apoptotic markers. Here, RSF1 is linked to esophageal squamous cell carcinoma.